​

Nevro (NVRO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NVRO Stock Forecast

Nevro stock forecast is as follows: an average price target of $5.84 (represents a 56.15% upside from NVRO’s last price of $3.74) and a rating consensus of 'Hold', based on 18 wall street analysts offering a 1-year stock forecast.

NVRO Price Target

The average price target for Nevro (NVRO) is $5.84 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $7.00 to $4.00. This represents a potential 56.15% upside from NVRO's last price of $3.74.

NVRO Analyst Ratings

Hold

According to 18 Wall Street analysts, Nevro's rating consensus is 'Hold'. The analyst rating breakdown for NVRO stock is 0 'Strong Buy' (0.00%), 6 'Buy' (33.33%), 9 'Hold' (50.00%), 3 'Sell' (16.67%), and 0 'Strong Sell' (0.00%).

Nevro Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Kallum TitchmarshMorgan Stanley$4.00$4.44-9.91%6.95%
Oct 15, 2024David RescottRobert W. Baird$5.00$4.921.63%33.69%
Aug 08, 2024Joanna WuenschCitigroup$6.89$5.6721.52%84.22%
Aug 08, 2024Richard NewitterTruist Financial$5.50$5.088.27%47.06%
Aug 07, 2024David RescottRobert W. Baird$8.00$5.0060.00%113.90%
Aug 07, 2024Matthew TaylorJefferies$7.00$4.8344.93%87.17%
Aug 07, 2024Adam MaederPiper Sandler$7.00$8.69-19.45%87.17%
Aug 07, 2024Nathan TreybeckWells Fargo$5.50$8.69-36.71%47.06%
Apr 11, 2024Anthony PetroneMizuho Securities$16.00$13.2820.48%327.81%
Apr 08, 2024Nathan TreybeckWells Fargo$14.00$13.295.34%274.33%
Jun 06, 2023Suraj KaliaOppenheimer$40.00$23.7168.72%969.52%
Feb 06, 2023Canaccord Genuity$72.00$39.1583.91%1825.13%
Jan 06, 2023Piper Sandler$38.00$40.00-5.00%916.04%
Dec 25, 2022Canaccord CanaccordCanaccord Genuity$67.00$40.1966.71%1691.44%
Dec 20, 2022Truist Financial$41.00$40.102.24%996.26%
Dec 12, 2022Wells Fargo$43.00$42.122.09%1049.73%
Feb 24, 2022David TurkalyJMP Securities$125.00$70.9676.16%3242.25%
Feb 24, 2022Robbie MarcusJ.P. Morgan$70.00$70.96-1.35%1771.66%
Dec 15, 2021Joanne WuenschCitigroup$94.00$82.1314.45%2413.37%

The latest Nevro stock forecast, released on Dec 02, 2024 by Kallum Titchmarsh from Morgan Stanley, set a price target of $4.00, which represents a -9.91% decrease from the stock price at the time of the forecast ($4.44), and a 6.95% increase from NVRO last price ($3.74).

Nevro Price Target by Period

1M3M12M
# Anlaysts1210
Avg Price Target$4.00$4.50$7.89
Last Closing Price$3.74$3.74$3.74
Upside/Downside6.95%20.32%110.96%

In the current month, the average price target of Nevro stock is $4.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 6.95% increase as opposed to Nevro's last price of $3.74. This month's average price target is down -11.11% compared to last quarter, and down -49.30% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2024CitigroupNeutralNeutralHold
Dec 02, 2024Morgan StanleyOverweightUnderweightDowngrade
Aug 08, 2024CitigroupSellNeutralUpgrade
Aug 08, 2024Wolfe ResearchPeer PerformUpgrade
Aug 07, 2024JefferiesUnderperformUnderperformHold
Aug 07, 2024Piper SandlerUnderweightUnderweightHold
Aug 07, 2024Wells FargoEqual-WeightUnderweightDowngrade
Aug 07, 2024JMP SecuritiesPerformMarket PerformDowngrade
Aug 07, 2024JMP SecuritiesPerformDowngrade
Jul 10, 2024CitigroupSellSellHold
May 22, 2024CitigroupNeutralSellDowngrade
Apr 03, 2024CitigroupNeutralNeutralHold
Feb 22, 2024RBC CapitalSector PerformSector PerformHold
Jan 12, 2024Truist FinancialSector PerformSector PerformHold
Dec 21, 2023RBC CapitalEqual-WeightEqual-WeightHold
Aug 02, 2023William BlairMarket PerformMarket PerformHold
Jun 06, 2023OppenheimerOutperformOutperformHold
May 15, 2023OppenheimerOutperformUpgrade
Feb 06, 2023Canaccord GenuityBuyBuyHold
Jan 06, 2023Piper SandlerNeutralUnderweightDowngrade
Dec 20, 2022Credit SuisseNeutralInitialise
Dec 20, 2022Keefe, Bruyette & WoodsUnderperformDowngrade
Dec 20, 2022Deutsche BankHoldDowngrade
Dec 20, 2022Cowen & Co.Market PerformDowngrade
Dec 20, 2022Alembic GlobalNeutralDowngrade
Dec 20, 2022BMO CapitalOutperformUpgrade
Dec 20, 2022Compass PointBuyUpgrade
Dec 20, 2022Morgan StanleyEqual-WeightOverweightUpgrade
Dec 20, 2022Canaccord GenuityHoldDowngrade
Dec 20, 2022Evercore ISIOutperformUpgrade
Dec 12, 2022Wells FargoOverweightEqual-WeightDowngrade
Oct 06, 2022Piper SandlerNeutralNeutralHold
Feb 25, 2022Morgan StanleyEqual-WeightEqual-WeightHold
Feb 24, 2022Wells FargoOverweightOverweightHold
Feb 24, 2022SVB LeerinkOutperformOutperformHold
Feb 24, 2022Piper SandlerNeutralNeutralHold

Nevro's last stock rating was published by Citigroup on Dec 11, 2024. The company gave NVRO a "Neutral" rating, the same as its previous rate.

Nevro Financial Forecast

Nevro Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$103.86M$108.81M$96.33M$113.84M$100.47M$104.21M$87.84M$102.76M$93.20M$102.33M$88.61M$109.73M$108.46M$56.39M$87.47M$114.37M$100.16M
Avg Forecast$112.30M$102.37M$108.13M$99.77M$109.66M$100.56M$103.39M$94.32M$100.18M$93.09M$107.11M$97.90M$112.26M$95.87M$108.19M$95.08M$113.42M$99.22M$104.34M$86.19M$100.26M$91.59M$102.32M$85.26M$107.92M$104.00M$37.86M$88.06M$111.80M$92.27M
High Forecast$119.98M$109.37M$115.53M$106.59M$117.16M$107.44M$110.47M$102.34M$101.11M$93.57M$107.11M$97.90M$112.33M$104.57M$115.59M$101.59M$121.19M$99.22M$104.34M$86.19M$100.26M$91.59M$102.32M$85.26M$107.92M$104.00M$37.86M$88.06M$111.80M$92.27M
Low Forecast$107.45M$97.94M$103.46M$95.46M$104.92M$96.22M$98.93M$89.75M$99.38M$92.60M$107.11M$97.90M$112.05M$94.58M$103.51M$90.97M$108.52M$99.22M$104.34M$86.19M$100.26M$91.59M$102.32M$85.26M$107.92M$104.00M$37.86M$88.06M$111.80M$92.27M
# Analysts545443481152241599131313137777945443
Surprise %-------------1.08%1.01%1.01%1.00%1.01%1.00%1.02%1.02%1.02%1.00%1.04%1.02%1.04%1.49%0.99%1.02%1.09%

Nevro's average Quarter revenue forecast for Dec 23 based on 4 analysts is $112.26M, with a low forecast of $112.05M, and a high forecast of $112.33M. NVRO's average Quarter revenue forecast represents a 8.09% increase compared to the company's last Quarter revenue of $103.86M (Sep 23).

Nevro EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts545443481152241599131313137777945443
EBITDA-------------$-25.56M$-25.64M$-36.32M$-19.36M$-18.75M$-20.55M$-30.04M$-24.00M$-44.13M$-13.59M$-20.68M$1.69M$-1.39M$-32.87M$-19.63M$-8.41M$-12.76M
Avg Forecast$-16.96M$-15.46M$-16.33M$-15.06M$-16.56M$-15.18M$-15.61M$-14.24M$-15.12M$-14.05M$-16.17M$-40.31M$-16.95M$-14.47M$-16.33M$-36.65M$-26.40M$-26.04M$-27.38M$-33.31M$-26.31M$-24.04M$-26.85M$-20.44M$-28.32M$-27.29M$-9.93M$-23.80M$-29.34M$-24.22M
High Forecast$-16.22M$-14.79M$-15.62M$-14.41M$-15.84M$-14.53M$-14.94M$-13.55M$-15.00M$-13.98M$-16.17M$-32.25M$-16.92M$-14.28M$-15.63M$-29.32M$-21.12M$-26.04M$-27.38M$-26.65M$-26.31M$-24.04M$-26.85M$-16.35M$-28.32M$-27.29M$-9.93M$-19.04M$-29.34M$-24.22M
Low Forecast$-18.12M$-16.51M$-17.44M$-16.09M$-17.69M$-16.22M$-16.68M$-15.45M$-15.26M$-14.13M$-16.17M$-48.37M$-16.96M$-15.79M$-17.45M$-43.98M$-31.68M$-26.04M$-27.38M$-39.98M$-26.31M$-24.04M$-26.85M$-24.53M$-28.32M$-27.29M$-9.93M$-28.56M$-29.34M$-24.22M
Surprise %-------------1.77%1.57%0.99%0.73%0.72%0.75%0.90%0.91%1.84%0.51%1.01%-0.06%0.05%3.31%0.83%0.29%0.53%

7 analysts predict NVRO's average Quarter EBITDA for Mar 21 to be $-20.44M, with a high of $-16.35M and a low of $-24.53M. This is -1311.54% lower than Nevro's previous annual EBITDA (Dec 20) of $1.69M.

Nevro Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts545443481152241599131313137777945443
Net Income-------------$-23.48M$-24.72M$-35.03M$-19.19M$81.51M$-24.99M$-34.33M$-30.13M$-50.08M$-21.59M$-29.56M$-7.13M$-9.98M$-41.06M$-24.89M$-13.74M$-17.85M
Avg Forecast$-19.28M$-23.14M$-21.90M$-26.50M$-19.55M$-19.44M$-21.21M$-30.29M$-29.08M$-30.40M$-26.03M$-46.06M$-18.26M$-28.70M$-25.75M$-41.88M$-33.15M$-8.29M$-29.85M$-38.07M$-31.65M$-32.21M$-27.08M$-29.21M$-12.33M$-21.70M$-60.08M$-30.17M$-23.38M$-31.41M
High Forecast$-18.20M$-21.84M$-20.67M$-25.01M$-18.45M$-18.35M$-20.02M$-17.31M$-24.98M$-28.70M$-24.56M$-36.85M$-15.34M$-16.40M$-24.30M$-33.50M$-26.52M$-8.29M$-29.85M$-30.46M$-31.65M$-32.21M$-27.08M$-23.37M$-12.33M$-21.70M$-60.08M$-24.13M$-23.38M$-31.41M
Low Forecast$-21.00M$-25.20M$-23.85M$-28.86M$-21.29M$-21.17M$-23.10M$-36.42M$-35.42M$-33.11M$-28.34M$-55.28M$-21.19M$-33.92M$-28.04M$-50.25M$-39.78M$-8.29M$-29.85M$-45.68M$-31.65M$-32.21M$-27.08M$-35.05M$-12.33M$-21.70M$-60.08M$-36.20M$-23.38M$-31.41M
Surprise %-------------0.82%0.96%0.84%0.58%-9.84%0.84%0.90%0.95%1.55%0.80%1.01%0.58%0.46%0.68%0.83%0.59%0.57%

Nevro's average Quarter net income forecast for Dec 22 is $-33.15M, with a range of $-39.78M to $-26.52M. NVRO's average Quarter net income forecast represents a -140.67% decrease compared to the company's last Quarter net income of $81.51M (Sep 22).

Nevro SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts545443481152241599131313137777945443
SG&A-------------$81.15M$86.76M$86.19M$80.65M$78.19M$83.97M$79.33M$82.64M$79.52M$73.88M$73.27M$67.07M$68.51M$60.17M$71.40M$76.01M$72.91M
Avg Forecast$87.61M$79.86M$84.36M$77.84M$85.55M$78.46M$80.67M$73.59M$78.16M$72.62M$83.57M$76.38M$87.59M$74.79M$84.41M$74.18M$90.90M$76.88M$80.85M$66.78M$77.69M$70.97M$79.29M$72.40M$83.63M$80.59M$29.33M$86.55M$86.63M$71.50M
High Forecast$93.61M$85.33M$90.14M$83.16M$91.41M$83.82M$86.19M$79.84M$78.88M$73.00M$83.57M$76.38M$87.64M$81.59M$90.18M$79.26M$109.08M$76.88M$80.85M$66.78M$77.69M$70.97M$79.29M$86.88M$83.63M$80.59M$29.33M$103.86M$86.63M$71.50M
Low Forecast$83.83M$76.41M$80.72M$74.47M$81.86M$75.07M$77.18M$70.02M$77.53M$72.25M$83.57M$76.38M$87.42M$73.79M$80.76M$70.97M$72.72M$76.88M$80.85M$66.78M$77.69M$70.97M$79.29M$57.92M$83.63M$80.59M$29.33M$69.24M$86.63M$71.50M
Surprise %-------------1.08%1.03%1.16%0.89%1.02%1.04%1.19%1.06%1.12%0.93%1.01%0.80%0.85%2.05%0.83%0.88%1.02%

Nevro's average Quarter SG&A projection for Dec 23 is $87.59M, based on 4 Wall Street analysts, with a range of $87.42M to $87.64M. The forecast indicates a 7.93% rise compared to NVRO last annual SG&A of $81.15M (Sep 23).

Nevro EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts545443481152241599131313137777945443
EPS-------------$-0.65$-0.69$-0.98$-0.54$2.30$-0.71$-0.98$-0.86$-1.44$-0.62$-0.85$-0.21$-0.29$-1.21$-0.78$-0.44$-0.58
Avg Forecast$-0.52$-0.62$-0.59$-0.71$-0.52$-0.52$-0.57$-0.81$-0.78$-0.81$-0.70$-1.05$-0.49$-0.77$-0.69$-1.05$-0.49$-0.22$-0.81$-1.10$-0.86$-0.87$-0.73$-0.85$-0.33$-0.59$-1.63$-0.99$-0.63$-0.85
High Forecast$-0.49$-0.59$-0.55$-0.67$-0.49$-0.49$-0.54$-0.46$-0.67$-0.77$-0.66$-0.99$-0.41$-0.44$-0.65$-0.99$-0.46$-0.22$-0.81$-1.10$-0.86$-0.87$-0.73$-0.85$-0.33$-0.59$-1.63$-0.99$-0.63$-0.85
Low Forecast$-0.56$-0.68$-0.64$-0.77$-0.57$-0.57$-0.62$-0.98$-0.95$-0.89$-0.76$-1.15$-0.57$-0.91$-0.75$-1.14$-0.53$-0.22$-0.81$-1.10$-0.86$-0.87$-0.73$-0.85$-0.33$-0.59$-1.63$-0.99$-0.63$-0.85
Surprise %-------------0.85%1.00%0.93%1.11%-10.25%0.88%0.89%1.00%1.65%0.85%1.00%0.63%0.49%0.74%0.79%0.70%0.68%

According to 13 Wall Street analysts, Nevro's projected average Quarter EPS for Dec 22 is $-0.49, with a low estimate of $-0.53 and a high estimate of $-0.46. This represents a -121.20% decrease compared to NVRO previous annual EPS of $2.30 (Sep 22).

Nevro Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
LUNGPulmonx$6.13$13.00112.07%Buy
SGHTSight Sciences$3.62$7.50107.18%Hold
RXSTRxSight$38.04$70.1484.38%Buy
KIDSOrthoPediatrics$22.46$39.5075.87%Buy
NVRONevro$4.05$5.8444.20%Hold
LIVNLivaNova$49.94$68.2536.66%Buy
CNMDCONMED$71.23$97.0036.18%Buy
OFIXOrthofix Medical$17.93$24.0033.85%
NPCENeuroPace$11.52$15.0030.21%Buy
IRMDIRadimed$53.00$60.0013.21%Buy
ITGRInteger$136.68$153.5012.31%Buy
FNAParagon 28$10.36$11.5011.00%Buy
CVRXCVRx$13.16$14.258.28%Buy
SRDXSurmodics$39.96$39.50-1.15%Buy
GKOSGlaukos$146.35$144.14-1.51%Buy

NVRO Forecast FAQ

Is Nevro a good buy?

No, according to 18 Wall Street analysts, Nevro (NVRO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 33.33% of NVRO's total ratings.

What is NVRO's price target?

Nevro (NVRO) average price target is $5.84 with a range of $4 to $7, implying a 56.15% from its last price of $3.74. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Nevro stock go up soon?

According to Wall Street analysts' prediction for NVRO stock, the company can go up by 56.15% (from the last price of $3.74 to the average price target of $5.84), up by 87.17% based on the highest stock price target, and up by 6.95% based on the lowest stock price target.

Can Nevro stock reach $6?

NVRO's highest twelve months analyst stock price target of $7 supports the claim that Nevro can reach $6 in the near future.

What is Nevro's current price target trend?

1 Wall Street analyst forecast a $4 price target for Nevro (NVRO) this month, up 6.95% from its last price of $3.74. Compared to the last 3 and 12 months, the average price target increased by 20.32% and increased by 110.96%, respectively.

What are Nevro's analysts' financial forecasts?

Nevro's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $407.94M (high $437.41M, low $389.81M), average EBITDA is $-61.59M (high $-58.853M, low $-66.041M), average net income is $-90.488M (high $-74.126M, low $-102M), average SG&A $318.26M (high $341.26M, low $304.12M), and average EPS is $-2.424 (high $-1.986, low $-2.732). NVRO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $422.57M (high $451.48M, low $404.3M), average EBITDA is $-63.799M (high $-61.042M, low $-68.165M), average net income is $-90.824M (high $-85.722M, low $-98.904M), average SG&A $329.68M (high $352.24M, low $315.43M), and average EPS is $-2.433 (high $-2.297, low $-2.65).

Did the NVRO's actual financial results beat the analysts' financial forecasts?

Based on Nevro's last annual report (Dec 2022), the company's revenue was $406.36M, beating the average analysts forecast of $403.17M by 0.79%. Apple's EBITDA was $-204M, beating the average prediction of $-113M by 80.17%. The company's net income was $3M, missing the average estimation of $-109M by -102.74%. Apple's SG&A was $322.14M, beating the average forecast of $315.42M by 2.13%. Lastly, the company's EPS was $0.08, missing the average prediction of $-2.621 by -103.05%. In terms of the last quarterly report (Sep 2023), Nevro's revenue was $103.86M, beating the average analysts' forecast of $95.87M by 8.34%. The company's EBITDA was $-25.559M, beating the average prediction of $-14.474M by 76.58%. Nevro's net income was $-23.479M, missing the average estimation of $-28.698M by -18.19%. The company's SG&A was $81.15M, beating the average forecast of $74.79M by 8.50%. Lastly, the company's EPS was $-0.65, missing the average prediction of $-0.769 by -15.46%